| Literature DB >> 33028637 |
Amy Lingel1, Haishuang Lin2, Yuval Gavriel3, Eric Weaver4, Pascal Polepole1, Virginia Lopez3, Yuguo Lei2, Thomas M Petro5, Beka Solomon3, Chi Zhang6, Luwen Zhang7.
Abstract
Zika virus (ZIKV) is a neurotropic flavivirus that causes several diseases including birth defects such as microcephaly. Intrinsic immunity is known to be a frontline defense against viruses through host anti-viral restriction factors. Limited knowledge is available on intrinsic immunity against ZIKV in brains. Amyloid precursor protein (APP) is predominantly expressed in brains and implicated in the pathogenesis of Alzheimer's diseases. We have found that ZIKV interacts with APP, and viral infection increases APP expression via enhancing protein stability. Moreover, we identified the viral peptide, HGSQHSGMIVNDTGHETDENRAKVEITPNSPRAEATLGGFGSLGL, which is capable of en-hancing APP expression. We observed that aging brain tissues with APP had protective effects on ZIKV infection by reducing the availability of the viruses. Also, knockdown of APP expression or blocking ZIKV-APP interactions enhanced ZIKV replication in human neural progenitor/stem cells. Finally, intracranial infection of ZIKV in APP-null neonatal mice resulted in higher mortality and viral yields. Taken together, these findings suggest that APP is a restriction factor that protects against ZIKV by serving as a decoy receptor, and plays a protective role in ZIKV-mediated brain injuries.Entities:
Keywords: Amyloid precursor protein; Zika virus; amyloid precursor protein (APP); brain specific; decoy receptor; flavivirus; immunology; innate immunity; interferon; intrinsic immunity; restriction factor
Mesh:
Substances:
Year: 2020 PMID: 33028637 PMCID: PMC7863900 DOI: 10.1074/jbc.RA120.015165
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157